Home > Journals > Medicine > Bulletin du cancer > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Bulletin du Cancer
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Follicular lymphoma: a therapeutic update


Bulletin du Cancer. Volume 92, Number 10, 10057-64, Octobre 2005, Electronic journal of oncology

Free Article  

Author(s) : Antoine Italiano, Antoine Thyss

Summary : Follicular lymphoma is the most common low-grade non Hodgkin’s lymphoma. This indolent disease is usually characterised by an indolent course with a continuous pattern of relapse and a median survival of 10 years. Radiotherapy can be curative in a small proportion of patients with very localized disease, but the majority of patients have advanced disease at diagnosis and it is not clear that any current therapy is curative in this situation. In theee last 5 years we have seen a dramatic increase in the number of patients receiving emerging therapies such as antibody therapy combined or not with chemotherapy, radioimmunotherapy or stem cell transplantation. In this article, we will review the available treatments of follicular lymphomas, with special emphasis on published phase III trials.

Keywords : follicular lymphoma, treatment, non-Hodgkin’s lymphoma

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]